This guideline covers parenteral nutrition (intravenous feeding) for babies born preterm, up to 28 days after their due birth date and babies born at term, up to 28 days after their birth. Parenteral nutrition is often needed by preterm babies, critically ill babies, and babies who need surgery.
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
Jobs at NICE. Includes current vacancies, roles, location and salary information.
The section of the NICE impact lung cancer report looking at how lung cancer is detected.
The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
Everything NICE has said on antimicrobial prescribing for common infections in an interactive flowchart
Everything NICE has said on parenteral nutrition (intravenous feeding) for newborn babies in an interactive flowchart.
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Everything NICE has said on fertility, pregnancy and childbirth in an interactive flowchart
Everything NICE has said on the use of antiseptics and antibiotics to manage impetigo in an interactive flowchart
Scientific advice case studies
NICE diagnostics assessment recommendations are prepared by an independent advisory committee called the diagnostics advisory committee. Standing...
Why are we running these sessions? We publish a lot of information. We want to make our website easier to find information that's relevant. We do this
A quick, easy way to access key information from NICE on social care topics.
Designed for developers of medicinal products and other similarly regulated technologies. Receive advice from NICE and various other European Health...
Our procedures and policies - includes complaints, declarations of interest and data protection policies.
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Advice from NICE to help you generate evidence to inform future NICE evaluations and to enable market access
Now we've left the European Union we can no longer offer the parallel advice service with the European Medicines Agency (EMA) via the European Network
Scientific advice for developers of pharmaceuticals
Evidence-based recommendations on the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi
Evidence-based recommendations on peginterferon beta-1a (Plegridy) for treating relapsing–remitting multiple sclerosis in adults
Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart
Everything NICE has said on diagnosing and managing community- and hospital-acquired pneumonia in an interactive flowchart
Everything NICE has said on preventing, identifying and managing neutropenic sepsis in children, young people and adults in an interactive flowchart
Everything NICE has said on multiple sclerosis in an interactive flowchart
Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart
Biographies and interests register for the indicator advisory committee
The NICE scientific advice team
NICE has developed a medtech innovation briefing (MIB) on National Early Warning Score systems that alert to deteriorating adult patients in hospital
NICE transparency of spend
Details, meeting dates and minutes of the independent technology appraisal committees
Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart
How we select the subjects for development into information, advice and guidance
NICE research projects and partners.
The Quality Standards Advisory Committees (QSAC) are independent committees that help to develop our quality standards . We have 3 committees who:
NICE quality standards set out priority areas for quality improvement in health and social care.
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
NICE's impact on dementia referral, diagnosis and care planning
How NICE's guidance has impacted on supporting carers of adults with dementia
Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults